Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Neonatal mouse immunity against group B streptococcal infection by maternal vaccination with recombinant anti-idiotypes

Abstract

We investigated whether immunization with recombinant anti-idiotypic antibody fragments mimicking the conformation of the capsular antigen can protect against infection by group B streptococcus, an important neonatal pathogen. Single-chain fragment-variable anti-idiotypes competed with the type III carbohydrate for binding to type-specific antibodies and elicited, in mice, the production of protective immunoglobulins reacting against the type III polysaccharide. Moreover, maternal immunization with soluble or phage-displayed fragments protected neonatal mice against streptococcal infection. These data indicate that recombinant anti-idiotypic antibodies may be useful in developing protein images of relevant carbohydrate epitopes and, ultimately, in preventing infections by encapsulated bacteria.

This is a preview of subscription content, access via your institution

Access options

Buy this article

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Baker, C.J. & Edwards, M.S. In Infectious Diseases of the Fetus and Newborn Infant (eds. Remington, J. & Klein, J.O.) 980–1054 (W.B. Saunders,–Philadelphia, PA 1995).

    Google Scholar 

  2. Rubens, C.E., Wessels, M.R., Heggen, L.M. & Kasper, D.L. Transposon mutagenesis of group B streptococcal type III capsular polysaccharide: correlation of capsule expression with virulence. Proc. Natl. Acad. Sci. USA 84, 7208–7212 (1987).

    Article  CAS  Google Scholar 

  3. Baker, C.J., Edwards, M.S. & Kasper, D.L. Role of antibody to native type III polysaccharide of group B streptococcus in infant infection. Pediatrics 68, 544–549 (1981).

    CAS  PubMed  Google Scholar 

  4. Baker, C.J. & Kasper, D.L. Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcal infection. N. Engl. J. Med. 294, 753–756 (1976).

    Article  CAS  Google Scholar 

  5. Baker, C.J. et al. Immunization of pregnant women with a polysaccharide vaccine of group B Streptococcus. N. Engl. J. Med. 319, 1180–1185 (1988).

    Article  CAS  Google Scholar 

  6. McLeod Griffiss, J., Apicella, M.A., Greenwood, B. & Makela, P.H. Vaccines against encapsulated bacteria: a global agenda. Rev. Infect. Dis. 9, 176–181 (1987).

    Article  Google Scholar 

  7. Molecular and Clinical Aspects of Bacterial Vaccine Development (eds. Ala'Aldeen, D.A.A. & Hormaeche, C.E.) (John Wiley & Sons, Chichester, UK, 1995).

  8. Lagergärd, T., Shiloach, J., Robbins, J.B. & Schneerson, R. Synthesis and immunological properties of conjugates composed of group B streptococcus type III capsular polysaccharide covalently bound to tetanus toxoid. Infect. Immun. 58, 687–694 (1990).

    PubMed  PubMed Central  Google Scholar 

  9. Paoletti, L.C. et al. Neonatal mouse protection against infection with multiple group B streptococcal (GBS) serotypes by maternal immunization with a tetravalent GBS polysaccharide-tetanus toxoid conjugate vaccine. Infect. Immun. 62, 3236–3243 (1994).

    CAS  PubMed  PubMed Central  Google Scholar 

  10. Kasper, D.L. et al. Immune response to type III streptococcal polysaccharide-tetanus toxoid conjugate vaccine. J. Clin. Invest. 98, 2308–2314 (1996).

    Article  CAS  Google Scholar 

  11. Paoletti, L.C., Kennedy, R.C., Chanh, T.C. & Kasper, D.L. Immunogenicity of group B Streptococcus type III polysaccharide-tetanus toxoid vaccine in baboons. Infect. Immun. 64, 677–679 (1996).

    CAS  PubMed  PubMed Central  Google Scholar 

  12. Madoff, L.C., Michel, J.L., Gong, E.W., Rodewald, A.K. & Kasper, D.L. Protection of neonatal mice from group B streptococcal infection by maternal immunization with beta c protein. Infect. Immun. 60, 4989–4994 (1992).

    CAS  PubMed  PubMed Central  Google Scholar 

  13. Larsonn, C., Ståhammar-Carlemalm, M. & Lindahl, G. Experimental vaccination against group B streptococcus, an encapsulated bacterium, with higly purified preparations of cell surface proteins rib and a. Infect. Immun. 64, 3518–3523 (1996).

    Google Scholar 

  14. Westerink, M.A.J., Giardina, P.C., Apicella, M.A. & Kieber-Emmons, T. Peptide mimicry of the meningococcal group C capsular polysaccharide. Proc. Natl. Acad. Sci. USA 92, 4021–4025 (1995).

    Article  CAS  Google Scholar 

  15. Agadjanyan, M. et al. Peptide mimicry of carbohydrate epitopes on human immunodeficiency virus. Nature Biotechnol. 15, 547–551 (1997).

    Article  CAS  Google Scholar 

  16. Westerink, M.A., Muller, E. & Apicella, M.A. In Idiotypic network and disease (eds. Cerney, J. & Hiernaux, J.) 107–119 (American Society for Microbiology, Washington, DC 1990).

    Google Scholar 

  17. McNamara, M., Ward, R.E. & Kohler, I.J. Monoclonal idiotype vaccine against Streptococcus pneumoniae infection. Science 226, 1325–1326 (1984).

    Article  CAS  Google Scholar 

  18. Stein, K.E. & Soderstrom, T. Neonatal administration of idiotype or anti-idiotype primes for protection against E. coli K13 infection in mice. J. Exp. Med. 160, 1001–1041 (1984).

    Article  CAS  Google Scholar 

  19. Westerink, M.A., Campagnari, A.A., Wirth, M.A. & Apicella, M.A. Development and characterization of an anti-idiotype antibody to the capsular polysaccharide of Neisseria meningitidis serogroup C. Infect. Immun. 56, 1120–1127 (1988).

    CAS  PubMed  PubMed Central  Google Scholar 

  20. Magliani, W. et al. Therapeutic potential of anti-idiotypic single chain antibodies with yeast killer toxin activity. Nature Biotechnol. 15, 155–158 (1997).

    Article  CAS  Google Scholar 

  21. Teti, G. et al. Specificity and protective activity of murine monoclonal antibodies directed against the capsular polysaccharide of type III group B streptococci. Hybridoma 11, 13–22 (1992).

    Article  CAS  Google Scholar 

  22. Wessels, M.R., Haft, R.F., Heggen, L.M. & Rubens, C.E. Identification of a genetic locus essential for capsule sialation in type III group B streptococci. Infect. Immun. 60, 392–400 (1992).

    CAS  PubMed  PubMed Central  Google Scholar 

  23. Finne, J., Leinoen, M. & Makela, P.H. Antigenic similarities between brain components and bacteria causing meningitis. Implications for vaccine development and pathogenesis. Lancet, 11, 355–357 (1983).

    Article  Google Scholar 

  24. Frasch, C.E. Vaccines for prevention of meningococcal disease. Clin. Microbiol. Rev. 2, S134–S138 (1989).

    Article  Google Scholar 

  25. Kortt, A.A. et al. Recombinant antineuraminidase single chain Fv antibody: characterization, formation of dimer and higher molecular mass multimers and the solution of the crystal structure of the scFv-neuraminidase complex. Eur.J. Immunol. 23, 206–211 (1994).

    Google Scholar 

  26. Gherardi, E. & Milstein, C. Original and artificial antibodies. Nature 357, 201–202 (1992).

    Article  CAS  Google Scholar 

  27. Teti, G., Tomasello, F. & Mancuso, G. Synthesis and immunological properties of an O-stearoyl polysaccharide from group B streptococci. J. Immunol. Res. 4, 67–72 (1992).

    Google Scholar 

  28. Mancuso, G., Tomasello, F. von Hünolstein, C., Orefici, G. & Teti, G. Induction of tumor necrosis factor alpha by the group- and type-specific polysaccharides from type III group B streptococci. Infect. Immun. 62, 2748–2753 (1994).

    CAS  PubMed  PubMed Central  Google Scholar 

  29. Aminoff, D. Methods for the quantitative estimation of N-acetylneuramic acid and their applications to hydrolisates of sialomucoids. Biochem. J. 81, 384–390 (1961).

    Article  CAS  Google Scholar 

  30. Dische, Z. & Shettles, R.B. A specific color reaction of methylpentoses and a spectrophotometric micromethod for their determination. J. Biol. Chem. 17, 595–599 (1948).

    Google Scholar 

  31. Teti, G., Mancuso, G. & Tomasello, F. Cytokine appearance and effects of anti-tumor necrosis factor antibodies in a neonatal rat model of group-B streptococcal infection. Infect. Immun. 61, 227–235 (1993).

    CAS  PubMed  PubMed Central  Google Scholar 

  32. Mancuso, G. et al. Beneficial effects of interleukin 6 in neonatal mouse models of group B streptococcal disease. Infect. Immun. 62, 4997–5002 (1994).

    CAS  PubMed  PubMed Central  Google Scholar 

  33. Cusumano, V. et al. Role of gamma interferon in a neonatal mouse model of group B streptococcal disease. Infect. Immun. 64, 2941–2944 (1996).

    CAS  PubMed  PubMed Central  Google Scholar 

  34. Mancuso, G. et al. Role of interleukin 12 in experimental neonatal sepsis caused by group B streptococci. Infect. Immun. 65, 3731–3735 (1997).

    CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Magliani, W., Polonelli, L., Conti, S. et al. Neonatal mouse immunity against group B streptococcal infection by maternal vaccination with recombinant anti-idiotypes. Nat Med 4, 705–709 (1998). https://doi.org/10.1038/nm0698-705

Download citation

  • Received:

  • Accepted:

  • Issue date:

  • DOI: https://doi.org/10.1038/nm0698-705

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing